Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOT 2 trial of heme arginate to reduce delayed graft function after deceased donor kidney transplantation
2018-000131-27Phase 3Unknown
- Sponsor
- University of Edinburgh
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in end-stage kidney disease (ESKD) comparing Normosang with Placebo (2 arms). Primary endpoint: Delayed graft function. Status: unknown.
02
Drugs
heme arginate
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2018-000131-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000131-27.